118 related articles for article (PubMed ID: 10195582)
21. Tumour T1 changes in vivo are highly predictive of response to chemotherapy and reflect the number of viable tumour cells--a preclinical MR study in mice.
Weidensteiner C; Allegrini PR; Sticker-Jantscheff M; Romanet V; Ferretti S; McSheehy PM
BMC Cancer; 2014 Feb; 14():88. PubMed ID: 24528602
[TBL] [Abstract][Full Text] [Related]
22. Estimation of the dividing fraction and potential doubling time of tumors using cytochalasin B.
Shibamoto Y; Streffer C
Cancer Res; 1991 Oct; 51(19):5134-8. PubMed ID: 1913638
[TBL] [Abstract][Full Text] [Related]
23. [In vivo evaluation of potential doubling time (Tpot) of tumors by flow cytometry: practical difficulties and possible solutions].
Gorisse MC; Desoize B; Carpentier Y; Nguyen TD
Bull Cancer; 1996 Oct; 83(10):825-34. PubMed ID: 8952632
[TBL] [Abstract][Full Text] [Related]
24. 31P-nuclear magnetic resonance spectroscopy in vivo of four human melanoma xenograft lines: spin-lattice relaxation times.
Olsen DR; Lyng H; Southon TE; Rofstad EK
Radiother Oncol; 1994 Jul; 32(1):54-62. PubMed ID: 7938679
[TBL] [Abstract][Full Text] [Related]
25. Effects of tamoxifen on potential doubling time of human breast cancer cell line determined by image cytometry of double fluorescent BrdU and DNA labeling.
Rostagno P; Moll JL; Birtwisle-Peyrottes I; Ettore F; Lagrange JL; Gioanni J; Caldani C
Anticancer Res; 1994; 14(5A):2025-32. PubMed ID: 7531416
[TBL] [Abstract][Full Text] [Related]
26. Comparison of BrdUrd and [3H]TdR incorporation to estimate cell proliferation, cell loss, and potential doubling time in tumor xenografts.
Zätterström UK; Johansson M; Källén A; Baldetorp B; Oredsson S; Wennerberg J; Killander D
Cytometry; 1992; 13(8):872-9. PubMed ID: 1459003
[TBL] [Abstract][Full Text] [Related]
27. Growth patterns and cell kinetics of human osteosarcoma xenografts in serial passages in nude mice analyzed by in vivo labelling with iododeoxyuridine.
Broström LA; Crnalic S; Löfvenberg R; Boquist L; Stenling R
J Cancer Res Clin Oncol; 1996; 122(3):141-46. PubMed ID: 8601561
[TBL] [Abstract][Full Text] [Related]
28. Cell proliferation in renal cell carcinoma. A clinical study with special reference to prognosis.
Larsson P
Scand J Urol Nephrol Suppl; 1994; 165():1-48. PubMed ID: 7871395
[TBL] [Abstract][Full Text] [Related]
29. Tumour cell repopulation during fractionated radiotherapy: correlation between flow cytometric and radiobiological data in three murine tumours.
Begg AC; Hofland I; Kummermehr J
Eur J Cancer; 1991; 27(5):537-43. PubMed ID: 1828958
[TBL] [Abstract][Full Text] [Related]
30. Microvascular permeability of human melanoma xenografts to macromolecules: relationships to tumor volumetric growth rate, tumor angiogenesis, and VEGF expression.
Graff BA; Bjørnaes I; Rofstad EK
Microvasc Res; 2001 Mar; 61(2):187-98. PubMed ID: 11254398
[TBL] [Abstract][Full Text] [Related]
31. Radiation-induced changes in phosphorus T1 values in human melanoma xenografts studied by 31P-MRS.
Olsen DR; Petersen SB; Rofstad EK
Magn Reson Imaging; 1997; 15(10):1187-92. PubMed ID: 9408139
[TBL] [Abstract][Full Text] [Related]
32. Blood flow in six human melanoma xenograft lines with different growth characteristics.
Lyng H; Skretting A; Rofstad EK
Cancer Res; 1992 Feb; 52(3):584-92. PubMed ID: 1732046
[TBL] [Abstract][Full Text] [Related]
33. Human malignant melanomas with varying degrees of melanin content in nude mice: MR imaging, histopathology, and electron paramagnetic resonance.
Atlas SW; Braffman BH; LoBrutto R; Elder DE; Herlyn D
J Comput Assist Tomogr; 1990; 14(4):547-54. PubMed ID: 2164537
[TBL] [Abstract][Full Text] [Related]
34. Potential doubling time in head and neck tumors treated by primary radiotherapy: preliminary evidence for a prognostic significance in local control.
Corvò R; Giaretti W; Sanguineti G; Geido E; Orecchia R; Barra S; Margarino G; Bacigalupo A; Vitale V
Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1165-72. PubMed ID: 8262843
[TBL] [Abstract][Full Text] [Related]
35. Tumor repopulation during radiotheraphy: quantitation in two xenografted human tumors.
Durand RE
Int J Radiat Oncol Biol Phys; 1997 Nov; 39(4):803-8. PubMed ID: 9369126
[TBL] [Abstract][Full Text] [Related]
36. The effect of dexamethasone on tissue water distribution and proton relaxation in Panc02 tumors.
Braunschweiger PG; Reynolds K; Nelson TR; Maring E
Magn Reson Imaging; 1987; 5(6):483-92. PubMed ID: 3431359
[TBL] [Abstract][Full Text] [Related]
37. Intratumor heterogeneity in perfusion in human melanoma xenografts measured by contrast-enhanced magnetic resonance imaging.
Bjørnaes I; Lyng H; Dahle GA; Kaalhus O; Rofstad EK
Magn Reson Imaging; 2000 Oct; 18(8):997-1002. PubMed ID: 11121704
[TBL] [Abstract][Full Text] [Related]
38. Assessment of extravascular extracellular space fraction in human melanoma xenografts by DCE-MRI and kinetic modeling.
Benjaminsen IC; Brurberg KG; Ruud EB; Rofstad EK
Magn Reson Imaging; 2008 Feb; 26(2):160-70. PubMed ID: 17692490
[TBL] [Abstract][Full Text] [Related]
39. Correlation between p53 gene expression and tumor-cell proliferation in oropharyngeal cancer.
Bourhis J; Bosq J; Wilson GD; Bressac B; Talbot M; Leridant AM; Dendale R; Janin N; Armand JP; Luboinski B
Int J Cancer; 1994 May; 57(4):458-62. PubMed ID: 8181849
[TBL] [Abstract][Full Text] [Related]
40. Influence of cellular, microenvironmental, and growth parameters on thermotolerance kinetics in vivo in human melanoma xenografts.
Rofstad EK
Cancer Res; 1989 Sep; 49(18):5027-32. PubMed ID: 2766273
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
